No Data
No Data
Is Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Recent Stock Performance Tethered To Its Strong Fundamentals?
joincare pharmaceutical group industry (600380.SH): First-time repurchase of 0.3777 million shares.
Gelonghui October 10th | Joincare Pharmaceutical Group Industry (600380.SH) announced that on October 10, 2024, the company repurchased 377,715 shares for the first time through centralized auction trading, accounting for 0.02% of the total share capital of the company (1,874,200,420 shares). The highest purchase price was 11.41 yuan/share, the lowest price was 11.21 yuan/share, and the total amount paid was 4.2842 million yuan (including fees).
Livzon Pharmaceutical Gets Nod to Register Endometriosis Treatment Drug
joincare pharmaceutical group industry (600380.SH): The new indication of injectable acetic acid quaprilin microspheres has been approved.
On October 8, Health元(600380.SH) announced that its holding subsidiary, Livzon Pharma Group Co., Ltd. (referred to as Livzon Pharmaceutical Group Inc.) and its holding subsidiary Shanghai Livzon Pharmaceutical Co., Ltd. have received the "Drug Registration Certificate" (Certificate Number: 2024S02341) issued by the National Medical Products Administration. The company's injection, acetic acid propylthiouraciland microsphere, with a new indication for "endometriosis", has been approved for registration.
Joincare Pharmaceutical Providing 100-Million-Yuan Loan to Controlling Subsidiary
Private Companies Are Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥825m Last Week
No Data
No Data